About Longdom Conferences:

Longdom Conferences hosts 200+ leading international conferences and virtual events annually. It is instrumental in bringing together experts and learners from all over the globe for mutual growth and effective research-oriented discussions. As per the present market demand and growth in the field of Surgery and Anesthesia research, Longdom Meetings is hosting its “2nd International Congress on Virology, Emerging Diseases and Vaccines”. This is scheduled for November 24-25, 2025 in Paris, France. The field of Virology, Emerging and Vaccines is one of the oldest scientific subjects, which is continuously evolving and has placed many landmarks in different research and development sectors. These fields are ecological science, agronomy, healthcare, drug discovery, food technology, and many other industrial areas. The Vaccine 2025 extends immense pleasure in inviting you to join us at this conference which will be focusing on the theme “New Innovations in the Field of Vaccines & Immunology”. We aim to engage, empower, evolve, and explore knowledge among attendees from all levels of scientific research on Surgery. This Virology, Emerging and Vaccines conference will focus on the core knowledge and major advances in the rapidly emerging fields by attracting eminent scholars, experts, and professionals globally.

Why join LONGDOM conferences?

Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand Launching and many more to explore

Who will be the participants?

Academic Deans and Directors | Professors and project leads | Postdocs and research scholars | Young scientists and students | CEOs/ CFOs/ Chairs/ Vice-Chairs | Marketing/ business and development teams | Experts who are keen-sighted for collaboration | Product designers and resolution workers | Business sales & services professionals | Associations and society members | Funding organizations & fundraisers

Important Scientific Sessions

Track- 1: mRNA Vaccine Innovations
mRNA vaccines revolutionized immunology with rapid, scalable production. Research explores improved stability, delivery, and broader applications beyond COVID-19, including cancer and infectious diseases. Advances focus on optimizing immune responses, reducing side effects, and expanding global accessibility for widespread immunization.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 2:Global Vaccine Equity
Ensuring vaccine access worldwide requires overcoming economic, logistical, and political barriers. Strategies include strengthening healthcare infrastructure, reducing costs, combating misinformation, and fostering global collaborations. Equitable distribution is crucial for controlling infectious diseases and preventing future pandemics in underserved regions.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track-3: COVID-19 Vaccine
COVID-19 vaccines saved millions of lives, yet challenges remain. Ongoing research focuses on booster doses, variant-specific formulations, long-term immunity, and equitable distribution. Addressing misinformation, vaccine hesitancy, and supply chain disruptions is essential for improving global immunization efforts and pandemic preparedness.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 4: Cancer Vaccines and Immunotherapy
Cancer vaccines harness the immune system to target tumors. Advances in neoantigen vaccines, dendritic cell therapy, and immune checkpoint inhibitors offer promising treatment strategies. Research continues to improve efficacy, safety, and personalized approaches for combating various cancer types and recurrence.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 5: Emerging Infectious Disease Vaccines
Rapid vaccine development is critical for pandemic preparedness. Novel platforms, cross-protective vaccines, and real-time surveillance aid in combating zoonotic threats. Research enhances response strategies to new viral outbreaks, antimicrobial resistance, and global health security challenges.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track-6: Vaccine Research & Development
Innovations in vaccine R&D include novel adjuvants, antigen engineering, and delivery technologies. Cutting-edge platforms like CRISPR, synthetic biology, and AI-driven predictive modeling enhance vaccine safety, efficacy, and scalability, accelerating responses to infectious diseases and emerging global health threats.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 7: Vaccine Safety & Immunogenicity
Ensuring vaccine safety involves rigorous clinical trials, post-market surveillance, and adverse event monitoring. Immunogenicity studies assess effectiveness and long-term protection. Public trust depends on transparent communication, regulatory oversight, and continuous research improving vaccine formulations and administration strategies.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 8: Pediatric Vaccines: Trends & Future
Childhood immunization protects against life-threatening diseases. Advances in combination vaccines, needle-free delivery, and new antigens for RSV and norovirus enhance protection. Research aims to improve durability, safety, and accessibility while addressing vaccine hesitancy and equitable global distribution.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 9: Vaccine Manufacturing Advances
Scalable, cost-effective production ensures global vaccine availability. Innovations include mRNA synthesis, cell-based platforms, single-use bioreactors, and automation. These advances improve efficiency, reduce production costs, and accelerate responses to outbreaks and emerging infectious diseases.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 10: Vaccine-Preventable Diseases
Diseases like measles, polio, and HPV remain significant threats. Expanding immunization programs, developing more effective vaccines, and addressing global disparities in vaccine coverage are essential to eliminating vaccine-preventable diseases and improving public health worldwide.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track-11: One Health: Zoonotic Disease Vaccines
Zoonotic diseases pose pandemic threats, necessitating vaccines targeting animal reservoirs. The One Health approach integrates human, animal, and environmental health to control rabies, avian flu, and coronaviruses, preventing outbreaks and reducing global health risks.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 12: Influenza & Respiratory Virus Vaccines
Influenza and respiratory viruses evolve rapidly, requiring updated vaccines. Research on universal flu vaccines, mRNA technology, and nasal spray formulations aims to provide broader, longer-lasting immunity, improving global preparedness and response to seasonal and pandemic respiratory infections.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 13: HIV Vaccines
Despite extensive research, an effective HIV vaccine remains elusive. Strategies like broadly neutralizing antibodies, mosaic immunogens, and mRNA-based vaccines show promise. Overcoming scientific and logistical challenges is critical to eradicating HIV and preventing new infections worldwide.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 14: AI & Big Data in Vaccine Research
AI and big data optimize vaccine development by predicting antigen structures, enhancing clinical trial design, and analyzing epidemiological trends. Machine learning accelerates discovery, improves vaccine efficacy, and strengthens public health surveillance for emerging infectious diseases.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 15: Innovative Vaccine Development
Emerging vaccine technologies include self-amplifying RNA, virus-like particles, and synthetic biology approaches. These innovations improve immune responses, safety, and distribution efficiency, paving the way for next-generation vaccines addressing infectious and non-communicable diseases.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 16: Pandemic Preparedness and Response
Strengthening preparedness requires rapid vaccine development, efficient stockpiling, and global distribution networks. Surveillance, scalable manufacturing, and public health infrastructure improvements enhance response capabilities, mitigating future pandemics and emerging infectious disease threats.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 17: Nanotechnology in Vaccines
Despite extensive research, an effective HIV vaccine remains elusive. Strategies like broadly Nanoparticles enhance vaccine delivery by improving antigen stability, targeting immune cells, and enabling controlled release. Applications include lipid nanoparticles, virus-like particles, and nano-adjuvants, leading to safer, more effective, and long-lasting immunization strategies.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 18: Next-Generation Vaccine Delivery Technologies
Advancements in vaccine delivery include microneedle patches, inhalable formulations, and self-administered devices. These technologies enhance patient compliance, reduce cold-chain dependency, and improve accessibility, particularly in resource-limited and remote regions.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Market Analysis:
The global vaccines market was valued at $43.2 billion in 2023, and is projected to reach $90.7 billion by 2035, growing at a CAGR of 6.4% from 2024 to 2035. Vaccines are essential tools for preventing infectious diseases and reducing their burden on public health. Government-led immunization programs, public health campaigns, and vaccination initiatives prioritize disease prevention, driving demand for vaccines and sustaining market growth. For instance, according to the World Health Organization (WHO), in January 2023, a total of 64 infectious diseases were reported globally, affecting 235 countries and regions. In addition, WHO estimated that more than 25 million outpatient visits and more than 2 million hospitalizations were attributable to rotavirus infections each year. 

A vaccine is a biological preparation that stimulates the immune system to recognize and protect against specific infectious diseases. It typically contains weakened or inactivated forms of pathogens (such as viruses or bacteria) or their components, which trigger an immune response without causing the disease itself. Vaccines help the body develop immunity to a particular disease by priming the immune system to recognize and fight off the pathogen if encountered in the future, thereby preventing, or reducing the severity of illness. 

Why to Attend/ Sponsor/ Exhibitor:
The 2nd International Conference on Virology, Emerging Diseases, and Vaccines is a unique and exciting opportunity, have been designed in an interdisciplinary manner with a multitude of tracks to showcase the new technology, the new products of your company, the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent research on Virology Applications.

Business networking is an avenue for vendors to have network and B2B meetings with “Top Scientists and Colleagues” and with an effective low-cost marketing method for developing sales and opportunities and contacts, based on referrals and introductions either face-to-face at meetings and gatherings, or by other contact methods such as Telephone, Email, Digital, and increasingly social and business networking websites.
Your sponsorship/exhibition will give your organization fantastic exposure to around 150 attendees and offer a unique opportunity to align your brand with this very highly successful, high-profile event.
Vaccine 2025 will provide a terrific and diverse platform to interact and network with fellow industry colleagues.

Benefits of Attending:

• To foster discussions, share expertise and exchange knowledge and best practices at all levels of the healthcare spectrum
• To encourage collaboration and enhance interactions at a global level
• Meet a range of specialists actively practicing in the field
• Strengthen your profile and position your organization as a key industry figure
• Develop new partnerships and networks with key decision-makers/influencers
• Open doors for your organization to connect and develop strategic relationships in a neutral and relaxed sales environment
• Get access to the targeted audience
• Brand Exposure – Promote your company’s message, products, and services through a national Conference marketing campaign
• First-hand live demonstrations to delegates
• To showcase new healthcare technologies and solutions in an intimate setting focused specifically on microbiology

Targeted Audience:

• Directors, CEO’s of Organizations
• Business Development Managers
• Chief Scientific Officers
• R&D Researchers from Pharma Industries
• Professors, Associate Professors, Assistant Professors
• PhD Scholars
• Association, Association presidents and professionals
• Noble laureates in Health Care and Medicine
• Research Institutes and members
• Manufacturing Companies
• Training Institutes